title: Study of combined vaccination against yellow fever and measles in infants from six to nine months.
abstract: A study has been carried out in the Ivory Coast to assess the efficacy of a combined vaccine against yellow fever and measles relative to that of each vaccine administered separately. Healthy children aged six to nine months were recruited and divided into two age groups: less than seven months (group I) and more than eight months (group II). In each group, they were randomly assigned to receive either yellow fever vaccine only (A), measles vaccine only (B), or the combined vaccine (C). The serological responses to measles and yellow fever were assessed in 219 initially seronegative children 45 days after immunization. More than 90% of the children developed yellow fever haemagglutination inhibiting antibodies. Neither age nor combination with measles vaccine influenced the responses to yellow fever vaccine. Measles haemagglutinational inhibiting antibodies were found in 97% of the children and the seroconversion rate was influenced neither by age nor by combination with yellow fever vaccine. Younger infants had lower titres of measles antibody. No particular adverse reactions were notified during the follow up. This study shows that combined yellow fever and measles vaccines are immunogenic in infants from the age of six months. Controlling yellow fever in endemic areas and the prevention of measles in young infants may greatly benefit by this combination.
authors.affiliation: Institut Pasteur de Cote d'Ivoire Secteur de Santé Rurale Adzope, France.
authors.forename: M
authors.initials: M
authors.lastname: Lhuillier
authors.forename: M J
authors.initials: MJ
authors.lastname: Mazzariol
authors.forename: S
authors.initials: S
authors.lastname: Zadi
authors.forename: N
authors.initials: N
authors.lastname: Le Cam
authors.forename: M C
authors.initials: MC
authors.lastname: Bentejac
authors.forename: L
authors.initials: L
authors.lastname: Adamowicz
authors.forename: F N
authors.initials: FN
authors.lastname: Marie
authors.forename: B
authors.initials: B
authors.lastname: Fritzell
mesh_terms: D000914:Antibodies, Viral / Q000096:biosynthesis; D002986:Clinical Trials as Topic; D007560:Cote d'Ivoire; D006801:Humans; D007223:Infant; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D015004:Yellow Fever / Q000517:prevention & control; D015005:Yellow fever virus / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine; D014765:Viral Vaccines